via University of Manitoba
Researchers have developed a new antibiotic that can help in the fight against resistant bacteria, and they hope it will reach the patients.
Every day, people die from simple infections even though they have been treated with antibiotics. This is because more and more bacteria have become resistant to the types of antibiotics that doctors can prescribe.
It’s a huge societal problem and a crisis that we must solve. For example, by developing new antibiotics that can defeat the resistant bacteria, says professor of chemistry at the Department of Physics, Chemistry and Pharmacy, Poul Nielsen.
Resistant bacteria are not only known from pig farms, where it is becoming increasingly difficult to keep the pigsties disease-free. Hospitals are also experiencing with increasing regularity that, for example, infectious diseases cannot be controlled in patients. Thus, an infection in a surgical wound can become life-threatening even if the operation went well.
Resistance can occur very quickly
According to Poul Nielsen, it is important to be at the forefront of the development because the list of resistant bacteria will only grow, which means that the treatment options will be reduced. It is therefore important to develop alternatives that can be used when the current antibiotics no longer work.
Resistance can occur very quickly, and then it’s essential that we’re ready, he says.
Together with his research assistant Christoffer Heidtmann and Janne Kudsk Klitgaard from the Department of Biochemistry and Molecular Biology as well as Clinical Microbiology, he has developed a substance that has the potential to become a new effective antibiotic, and SDU has now taken out a patent for it.
Unlike traditional antibiotics such as penicillin, sulfonamides and tetracyclines, this antibiotic is from the pleuromutilin class.
The substance is developed in a medicinal chemistry project and recently published in the Journal of Medicinal Chemistry.
Out to doctors and patients – how?
The substance fights both resistant enterococcus, streptococcus and staphylococcus bacteria. The substance and the pleuromutilin class do this via a unique mechanism of action, which also causes resistance to develop at a very slow pace.
So far, the substance has been tested on bacteria and human cells. The next step towards becoming an approved drug is animal studies and then clinical studies in humans.
Maybe we should consider this a societal task, rather than a task that will only be solved if it’s financially attractive.
Poul Nielsen, professor
– If this substance is to reach doctors and patients as a drug, comprehensive and cost-intensive further development efforts are needed, which we can only initiate under the auspices of the university.
– The big pharmaceutical companies have that kind of money, but they are traditionally not interested in this kind of tasks, because they are not financially attractive, says Poul Nielsen.
Should it be a societal task?
According to Poul Nielsen, there are several reasons why it is not financially attractive to develop new antibiotics:
- Antibiotics are only taken for days or weeks. There is more money in drugs for chronically ill people, such as antidepressants or blood pressure medicine.
- Newly developed antibiotics will be backups and not used until the current antibiotics no longer work. So earnings are not just around the corner.
- The bacteria can also become resistant to a new antibiotic, and then it has to be taken off the market again.
– However, this doesn’t change the fact that the world community is in dire need of new effective drugs against antibiotic resistance. Maybe we should consider this a societal task, rather than a task that will only be solved if it’s financially attractive, says Poul Nielsen.
He and his colleagues hope that the work of further developing their new antibiotic can continue. Whether it will happen, and whether it will be in a public or private context, only time will tell.
Original Article: New weapon against resistant bacteria
More from: University of Southern Denmark
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Antibiotics
- Sophisticated mechanism that bacteria use to resist antibiotics
Researchers have discovered a significant and previously unknown mechanism that many bacteria use to resist antibiotics.
- New trial offers double the traditional course of antibiotics for patients with life threatening infections
Hospital patients who develop infections where 10% of sufferers die will be offered double the traditional course of antibiotics in a new trial.
- Bipartisan bill on antibiotics faces crucial stretch
A health care bill is facing criticism from some experts who say it could lead to huge spending on new antibiotic drug development that may not improve patient outcomes in the long run. The bipartisan ...
- Antibiotics may increase your risk of life-threatening condition
Taking antibiotics "increases your risk" of a life-threatening condition, experts have warned. It could lead to killing healthy gut bacteria which could trigger asthma. Martin Blaser, director of ...
- Early Exposure to Antibiotics Can Cause Permanent Asthma and Allergies
Early exposure to antibiotics kills healthy bacteria in the digestive tract and can cause asthma and allergies, a new study demonstrates.
Go deeper with Google Headlines on:
Antibiotics
Go deeper with Bing News on:
Antibiotics development
- Sophisticated mechanism that bacteria use to resist antibiotics
Researchers have discovered a significant and previously unknown mechanism that many bacteria use to resist antibiotics.
- New trial offers double the traditional course of antibiotics for patients with life threatening infections
Hospital patients who develop infections where 10% of sufferers die will be offered double the traditional course of antibiotics in a new trial.
- Taking This Common Antibiotic After Sex Might Help Prevent STDs
A new study claims a common antibiotic can help prevent STDs, which have been on the rise following the pandemic.
- Bipartisan bill on antibiotics faces crucial stretch
A health care bill is facing criticism from some experts who say it could lead to huge spending on new antibiotic drug development that may not improve patient outcomes in the long run. The bipartisan ...
- Early Exposure to Antibiotics Can Cause Asthma and Allergies
Early exposure to antibiotics kills healthy bacteria in the digestive tract and can cause asthma and allergies, a new study demonstrates. The study, published in Mucosal Immunology, has provided the s ...
Go deeper with Google Headlines on:
Antibiotics development








